How does cannabis actually cure cancer?

The information in this guide is designed to help you make informed decisions about your personal health based on established facts and whether or not Cannabis Oil is the right intervention for you.

Mankind has been evolving slowly over millions of years, naturally and progressively alongside nature. Until the time of the Industrial Revolution of the 17^th century, ‘We’ knew not of Toxins and unnatural chemicals, by-products of our ‘progress’ as we quickly realised that our lives could be made far simpler with our new found technology & the invention of petrol, chlorine, paints, plastics and also the by-products of these chemical processes. Gasses and toxic fumes spill from engines, leach from nylon carpets and plastics all around us every day, day after day, year after year, for our whole lives.

Modern day living exudes a cloud of unnatural substances that we have come to accept as normal in our daily lives while we are awake and also asleep.

Our body’s did not evolve naturally alongside these manmade substances, which is why we now see so many new diseases and illnesses that were unheard of only 100 years ago.

Cancer is a leading cause of death in industrialised countries. So far, the treatments available from the pharmaceutical company’s mostly have limited efficacy, as well as a significant toxicity and strong undesirable side effects. Cancer has found its way into the lives of millions worldwide, we all know at least one loved one or family friend stricken with the disease, to name only one illness associated with 21^st century living.

The backbone of the Human Immune System is known as the ‘Endo-Cannabinoid System’ and it is responsible for fighting off infection while we go about our Daily lives.

This was perfect for keeping our body’s free from illness and disease for over 6 million years, until the time of the Industrial revolution when our body’s had to start fighting of infections and diseases that it had never previously encountered in our 6-million-year evolutionary process. These symptoms are caused by the passive proximity to these new man-made chemicals and the situation made far worse by the fact that we were/are ignorant of the unknown dangers. Just as smoking cigarettes was seen to be beneficial to one’s health in the early 20^th century, we now know that the truth is actually the complete opposite. Although as late as the 1950’s medical research into lung cancer suggested a link with smoking cigarettes, but it was only a hypothesis at that time, yet we now globally accept that smoking is lethal.

While we are awake and asleep, our immune system is busy fighting off invisible attackers that we know virtually nothing about, yet our immune systems carry on the silent war with the onslaught of unnatural chemicals, foods, radiations and gasses.

This onslaught takes its toll on our body’s ‘Endo-Cannabinoid System’, depleting it immensely as it is fighting off this bombardment of alien chemicals it becomes low. This is when the unlucky will become affected by cancers and other 20^th century diseases as the body’s Endo-Cannabinoid System is fighting a war on substances unknown to it in its natural evolutionary process.

Cannabis has been used in medicine for over 7,000 years with not one recorded death attributed to the plant (a farm worker was crushed to death by a 1-Ton bail of hemp in 1922, but apart from that nasty mishap, that is the only recorded death from the cannabis plant). It was known to be used in the anointing oil by the Israelites in the time of Christ, used by the Romans to treat Asthma, and also prevalent in every doctor’s medicine bag right up until the 1950’s. After this time its use was relegated to obscurity by ‘New’ modern drugs who’s testing only goes back 20 or 30 years at the most and the long term side effects are literally unknown of as yet. How common is it that we are prescribed a drug for symptoms of illness, and to counteract the side effects of this treatment we need also consume other manmade drugs to effect the contraindications of the first?

For the most part this is wholly unnecessary.

It is a coincidence that the cannabis plant is the only plant growing on our planet that contains ‘Cannabinoids’. Cannabinoids are the constituent parts of the Cannabis plant that are found in the plants natural oils……..and also found in the immune system of all living mammals.

When we consume Cannabis products, the available cannabinoids in the plant travel into the blood stream and are deposited within the Endo-Cannabinoid system, topping up the body’s natural defence system allowing ergonomic healing to take place within the individual. Cancers will become surrounded by a red ‘barrier’ and in many cases this barrier will stop the cancers development and hopefully eat away at the cancer until it is dead.

The current legislation on medical Cannabis is not adapted to the medical and scientific information currently available today.

We all know how important it is to have a good quality of life when fighting any disease. The current legislation on medical Cannabis is in the processes of great change. Unfortunately, the vital cannabinoids, in particular THC (Tetrahydrocannabinol), are still greatly restricted and not widely available. The legal amount of THC in similar preparations of cannabis oil still falls well short of what our body needs to boost our natural endocannabinoid system and allow it to fight disease and illness efficiently, naturally and with almost no side effects.

The ‘Endo-Cannabinoid’ system is the ‘back-bone’ of the human immune system. It helps the human body fight diseases on our behalf while we carry on living our lives. It is under constant attack as we sleep, work and go about our day. When you stub your toe, bang your head, get cancer or get poorly, it is Endocannabinoids that are First responders on the scene at the damaged infected location. Cannabinoids are part of human wellbeing. We eat foods containing chemicals that are harmful to us. Then go home to a house full of chemicals, gasses and radiation that go undetected by our senses as they are odourless, colourless and often tasteless.  Everyone of us knows someone with cancer and, statistically, 1 in 3 people will be affected by cancer in their lifetimes. We did not evolve as a species with these new toxins, chemicals, gasses and drugs, and for the last ten generations our families have endured a more polluted planet than their forefathers. Our body’s defences are too slow to naturally evolve at this rapid rate to match that of the constantly-changing new and dangerous by-products of ‘progress’.  Whilst this is going on inside us, the Endocannabinoid system is silently drained and depleted.

Cannabinoids are completely natural and the body’s first line of defence against damage and disease. The female cannabis plant contains the necessary cannabinoid compounds to boost and bolster our individual immune system, in effect, topping it up.

How does Cannabis cure cancer?        

Very simply, when THC, derived and extracted from the cannabis plant, connects to the CB1 or CB2 cannabinoid receptor site on the cancer cell, it causes an increase in ceramide synthesis which drives cell death. A normal healthy cell does not produce ceramide in the presence of THC, thus is not affected by the cannabinoid.

In every cell in the body we find a family of inter-convertible sphingolipids that specifically manage the life and death of that individual cell. This profile of factors is called the “Sphingolipid Rheostat.”  If endogenous ceramide (a signalling metabolite of sphingosine-1-phosphate) is high, then cell death (apoptosis) is imminent. If ceramide is low, the cell is strong in its vitality. 

The cancer cell dies, not because of cytotoxic chemicals, but because of a tiny little shift in the mitochondria. Within most cells there is a cell nucleus, numerous mitochondria (hundreds to thousands), and various other organelles in the cytoplasm. The purpose of the mitochondria is to produce energy (ATP) for cell use. As ceramide starts to accumulate, turning up the Sphingolipid Rheostat, it increases the mitochondrial membrane pore permeability to cytochrome c, a critical protein in energy synthesis. Cytochrome c is pushed out of the mitochondria, killing the source of energy for the cell.

Ceramide also causes genotoxic stress in the cancer cell nucleus generating a protein called p53, whose job it is to disrupt calcium metabolism in the mitochondria. If this weren’t enough, ceramide disrupts the cellular lysosome, the cell’s digestive system that provides nutrients for all cell functions. Ceramide, and other sphingolipids, actively inhibit pro-survival pathways in the cell leaving no possibility at all of cancer cell survival.
The key to this process is the accumulation of ceramide in the system. This means taking therapeutic amounts (known as micro-dosing) of CBD and THC, steadily, over a period of time, keeping metabolic pressure on this cancer cell death pathway. 
How did this pathway come to be? Why is it that the body can take a simple plant enzyme and use it for profound healing in many different physiological systems? This Endocannabinoid system exists in all animal life, just waiting for its matched cannabinoid activator. Our own Endocannabinoid system covers all cells and nerves. It is the messenger of information flowing between our immune system and the central nervous system (CNS). It is responsible for neuroprotection, and micro-manages the immune system. This is the primary control system that maintains homeostasis; our wellbeing. How does this happen at the cellular level? And where does the body make the endocannabinoids? Here we see that endocannabinoids have their origin in nerve cells right at the synapse. When the body is compromised through illness or injury it calls insistently to the Endocannabinoid system and directs the immune system to bring healing. If these homeostatic systems are weakened, it should be no surprise that cannabinoids are therapeutic. It helps the body in the most natural way possible.

https://www.youtube.com/watch?v=JnQGrnh7Q7o

How is Medical Cannabis Administered?

Medical cannabis can be administered using a variety of methods, including vaporizing or smoking dried flower heads, eating extracts, taking capsules or using oral sprays.

Synthetic cannabinoids are available as prescription drugs in some countries E.g. Dronabinol and Nabilone®, *Sativex®, & Marinol®. Recreational use of cannabis is illegal in most parts of the World, but the medical, and recreational use of cannabis is legal in certain countries, including Austria, Canada, Czech Republic, Finland, Germany, Israel, Italy, the Netherlands, Portugal and Spain.

* Sativex for example – Sativex® is an oromucosal spray of a formulated synthetic extract of the Cannabis Sativa plant. It contains only two of the principal cannabinoids delta-9-tetrahydrocannibinol (THC) and cannabidiol (CBD) in a 1:1 ratio as well as specific minor cannabinoids and other non-cannabinoid components. 

Modern History – The Beginning of Cannabinoid Science

Despite the medicinal and recreational use of cannabis for centuries, the identity of its main psychotropic constituent remained unknown until 1964 when Raphael Mechoulam, Yechiel Gaoni, and Habib Edery from the Weizmann Institute of Science in Rehovot, Israel, isolated tetrahydrocannabinol (THC). It was subsequently established that this compound is responsible for the psychotropic effects of the plant, one early hypothesis being that since THC is so hydrophobic it induces these effects by interacting with cell membrane lipids. However, as more was learnt about the pharmacology of THC and of synthetic cannabinoids such as CP55940 that induce THC-like effects it became increasingly likely that these effects must be mediated by a distinct family of receptors.

The Discovery of Cannabinoid Receptors

It was not until 1988 during experiments using radiolabelled CP55940 that the first of these receptors was actually identified. Aptly named cannabinoid receptor type 1 (CB1) it was located at the synapses of the central nervous system and importantly, the peripheral terminals of sensory neurones. CB1 receptors are thought to be the most widely expressed G protein-coupled receptors in the brain but are also found in peripheral tissues including peripheral nerves and non-neuronal tissues such as muscle, liver and fat. A few years later a second receptor (CB2) was identified through homology cloning. This is predominantly present in the cells of the immune system.

The Role of Ligands

The discovery of cannabinoid receptors prompted the hypothesis that the body must produce one or more endogenous ligands (naturally occurring molecules) that bind to the receptor. The first such endogenous compound was isolated in 1992, just two years after the cloning of the CB1 receptor. This was the endogenous cannabinoid (endocannabinoid) anandamide (AEA) and investigators have shown that it functions as a CB1 receptor partial agonist. A second endocannabinoid, 2-arachidonoyl glycerol (2-AG), was discovered a couple of years later and in the following decade several other endogenous molecules that can activate CB receptors were identified. Evidence also emerged that the Endocannabinoid system is transiently activated under certain stressful conditions to restore homeostasis.

Ligand biosynthesis and degradation

Once endogenous cannabinoids were identified it was possible to demonstrate that they are removed from their sites of action by cellular uptake processes and to identify the intracellular enzymes responsible for both their production and metabolic degradation. Diacylglycerol lipase (DAGL) is a key enzyme in the biosynthesis of the 2-AG whereas N-arachidonoyl phosphatidylethanolamine-phospholipase D plays an integral role in the production of AEA. Both AEA and 2-AG are inactivated via ester bond hydrolysis and the primary enzymes responsible for these reactions are fatty acid amide hydrolase (FAAH) and monoacylglycerol lipase (MAGL) respectively. Endocannabinoid ligands are synthesized on demand rather than stored by the body.

Manipulation of the endocannabinoid system

There is now good evidence that the endocannabinoid system can be activated not only with compounds that directly target cannabinoid CB1 and/or CB2 receptors but also with inhibitors of endocannabinoid cellular uptake or of the intracellular metabolism of endocannabinoids by FAAH or MAGL. This has prompted a search for phytocannabinoids that can augment endocannabinoid levels by inhibiting these processes or indeed by activating biosynthetic enzymes such as DAGL in a manner that would enhance the protective role that increased endocannabinoid release plays in certain disorders.

Other endocannabinoid targets

Interestingly, in some scenarios phytocannabinoids, synthetic cannabinoids and endocannabinoids are still able to induce certain effects even when the cannabinoid receptors have been blocked with an antagonist; evidence for the existence of non-CB receptor targets for these molecules. Further studies have demonstrated that these targets include transient receptor potential (TRP) channels such as TRPV1 and TRPM8, the peroxisome proliferator activated receptors (PPAR) alpha and gamma, G protein-coupled orphan receptors such as GRP55, certain ion channels (e.g. calcium channels), transmitter-gated ion channels (e.g. glycine receptors) and finally established non-cannabinoid G protein-coupled receptors(e.g. acetylcholine muscarinic receptors). We are now exploring the potential of phytocannabinoids to interact with targets other than CB1 or CB2 receptors in the search for therapeutically interesting pharmacology.

True Multi-strain Full Spectrum Cannabinoid products are best blended with only pure Organic Hemp seed Oil which is the perfect carrier solution because it is composed of nearly 85% essential fatty acids (EFAs) alone and offers the richest, most balanced natural source of EFAs. In fact, the amount of alpha-linolenic and linolenic acid in 15 ml (one tablespoon) of hemp seed oil provides more than the daily EFA requirements suggested by the FDA. In addition, hemp seed oil is lower in saturated fatty acids than other comparable oils, is easily digested and has been shown to alleviate symptoms of atopic dermatitis (eczema) and even psoriasis, Hemp seed oil is also the highest amount of Omega-3 found on the planet.

Hemp seed oil also exhibits the highest total phenolic content and antioxidant activity compared to all other plant-based oils (with the exception of pumpkin seed oil). Naturally occurring phenolic compounds are known to play a key role in reducing the risk of cancer, relieving systemic inflammation, acting as a powerful antioxidant and promoting free radical elimination. The anti-carcinogenic properties of hemp seed oil work by causing apoptosis (cell death), inhibiting the cell cycle and preventing the abnormal proliferation of cells characteristic of cancerous tumours.

WARNING:  THIS PRODUCT IS ILLEGAL IN THE UK

FOR MEDICINAL USE ONLY

WARNING: This product contains high-grade cannabis oil. This product is not CBD made from legal Hemp Oil – it is made from the flowering heads of the female cannabis plant. Cannabis and preparations made from the cannabis plant are classified as ‘Class B’ under the 1971 Misuse of Drugs Act and possession of cannabis or its preparations can incur a prison sentence of up to 5 years.

DO NOT Drive

DO NOT Operate Machinery

THIS MEDICATION WILL TRIGGER A POSITIVE DRUG TEST RESULT

This product can cause drowsiness, dizziness, hallucinations and lethargy. To avoid these symptoms, take at night 1 hour before bedtime, preferably on an empty stomach so that the effects come on faster. Some people may wish to take it at another time of day or on a full stomach. This is fine. Take the oil as you feel best but be aware that the effects can take up to seven hours to be felt if taken on a full stomach. Plan this into your daily schedule to avoid inconvenient timing of unwanted effects (the high feeling associated with cannabis).

Uses based on tradition or theory. The below uses are based on tradition or scientific theories. They often have not been thoroughly tested in humans and safety and effectiveness have not always been proven. Some of these conditions are potentially serious, and should be evaluated by a qualified healthcare provider. Acne, ADHD, aging, alcohol or drug dependency, alcohol withdrawal, allergies (prevention/treatment), Alzheimer’s disease, angioedema (swelling under the skin), ankylosing spondylitis (inflammation of spine joints), anti-aging (including skin), antioxidant, anxiety, arthritis (caused by psoriasis), asthma, autoimmune diseases, bipolar disorder, blood pressure control, blood thinner, burns, cancer, chest pain, childbirth, claudication (leg pain from clogged arteries), constipation, cough, dandruff, depression, detoxification (narcotic), diabetes, digestion, drug withdrawal, dry skin, energy, erectile dysfunction, fatigue, fever, food uses, fungal infections, general health maintenance, hair growth, heart disease, haemorrhoids, high cholesterol, hormone regulation, immune system problems, improving blood flow, improving breathing, improving urine flow, increased muscle mass, increasing breast milk, inflammation, inflammatory bowel disease, inflammatory conditions, interstitial cystitis (chronic bladder inflammation), irregular heartbeat, leprosy, leukaemia, lichen planus (itchy mouth rash), liver protection, lymph flow enhancement, menopause, menstrual pain, migraine, mood, movement disorders, muscle relaxation, nausea, nervous system disorders, nervous system function, neural tube defects, neuroprotection (protect the nervous system), osteoporosis (weakening of the bones), pain from nerve disorders, paralysis after stroke, pregnancy and labour, promoting flow of breast milk, psoriasis (skin redness and irritation), Raynaud’s disease (blood vessel disorder), saliva production control, sedative, sexual performance, shortness of breath, skin conditions (cracked skin and nails), spinal cord injury, stomach disorders (increase stomach acid), stomach spasms, stress, stroke, tendonitis (tendon inflammation), thrombosis (clot in blood vessel), uterus contraction, urinary tract disorders, urinary tract infection, varicose veins, vitamin C deficiency, vomiting, wound healing.

Safety

There is no guarantee of strength, purity or safety of products and effects may vary. You should always read product labels. If you have a medical condition, or are taking other drugs, herbs, or supplements, you should speak with a qualified healthcare provider before starting a new therapy. Consult a healthcare provider immediately if you experience side effects.

Avoid if allergic or sensitive to cannabinoids or to plants of the *Cannabaceae family. Asthma, hives, pink eye, and runny or stuffy nose have been reported.

Allergies:

*Cannabaceae is a small family of flowering plants. As now circumscribed, the family includes about 170 species grouped in 11 genera, including Cannabis (hemp, marijuana), Humulus (hops) and Celtis (hackberries).

Side Effects and Warnings

Side effects have mostly been linked to THC, the active ingredient in cannabis sativa. Dizziness is a common side effect. Cannabis may have effects on almost every organ system in the body, including the central nervous, heart, endocrine, and immune systems. Use cautiously with alcohol.

Know that all effects from taking the oil wear off (the longer you take the oil the more your body will get used to it and these effects will pass as you build a tolerance to the Full Spectrum High-Grade THC Cannabinoid Oils. If you have an uncomfortable high effect for example, it will pass. Drink plenty of water and try to relax into the feeling and lay down in bed for a few hours. It is far better to start the oil off with literally just ONE single DRIP of the 15ml pipetted bottle – the next day take 2 drips – the 3rd day 3 drips and so on. HALF of one full pipette being approx. 30 single DRIPS is a daily dosage 45mg of multi-strain True full spectrum cannabinoid oil.
Multi-Strain True Full Spectrum Cannabinoid oil is significantly stronger due to the Entourage Effect with more available cannabinoids present in the oil than for instance a single-strain product, and will be felt as a strong intoxication by most people. Remember a tolerance will build over the weeks as you get used to the feeling that cannabinoids bring to your system. Know that this feeling, weather enjoyed or not, is bringing with it a wave of health benefits by fortifying your immune system.

As the oil contains THC (which is one of the main cannabinoids that kills cancer) you can also get some effects which are harmless but sometimes hard to tolerate. These include:
Sleeping a lot (most common) – Feeling High (spaced out feeling) – Tired – Room spinning – Groggy feeling – Increased/Decreased appetite – Anxiety – Giggly – Laughing. It is advised not to drive on the oil until these feelings pass which usually takes 4-6 hours. Everyone is different. Don’t panic, try to enjoy the feeling, know what is happening and know it is normal and will pass. Trying to fight it will just make you more anxious and it always passes. If you have a high effect and having trouble handling it, try slightly less for a few days until the body has adjusted fully. If you are looking after someone, reassure them when it’s happening that its normal and will pass.

Interaction of Cannabidiol and Alcohol in Humans

Cannabis may increase the risk of bleeding. Caution is advised in people with bleeding disorders or those taking drugs that may increase the risk of bleeding. Dosing adjustments may be necessary.

Cannabis may affect blood sugar levels. Caution is advised in people with diabetes or blood sugar problems, and in those taking drugs, herbs, or supplements that affect blood sugar. Blood sugar levels may need to be monitored by a qualified healthcare professional, including a pharmacist, and medication adjustments may be necessary. Cannabis may cause low blood pressure. Caution is advised in people who have blood pressure disorders or those taking drugs or herbs and supplements that lower blood pressure.

Use cautiously in people who have liver disease or those using agents toxic to the liver. Use cautiously in people who are taking barbiturates, antipyrine, or central nervous system (CNS) depressants. Cannabis may interfere with the way the body processes certain agents using the liver’s cytochrome P450 enzyme system. As a result, the levels of these agents may be increased in the blood and may cause increased effects or potentially serious adverse reactions.

People using any medications should check the package insert and speak with a qualified healthcare professional or pharmacist about possible interactions. Use cautiously in people who are on oestrogen therapy.

Use cautiously in people who are taking p-glycoprotein-regulated drugs.

Use cautiously in people who have or are at risk of eye problems. Cannabis may cause eye problems and dry eyes, and it may increase eye pressure.

Use cautiously when consuming foods or supplements that contain cannabis seeds or oil. This product contains a very high level of THC that will trigger a positive drug test result.

Use cautiously in people who are at risk of seizure or those using anti-seizure drugs. Cannabis may cause seizures.

Use cautiously in people with stomach disorders. Cannabis may cause stomach problems such as a bad taste, burning or swelling tongue, diarrhoea, dry mouth, increased appetite, indigestion, mouth ulcers, nausea, pain, and vomiting

Use caution if driving or operating heavy machinery.

Use cautiously in all otherwise healthy people who are not taking any medications. Cannabis may cause disorientation, dizziness, headaches, and fatigue, a feeling of intoxication, light-headedness, and reduced attention.

Avoid if allergic or sensitive to cannabinoids or to plants of the Cannabaceae family. Asthma, hives, pinkeye, and runny or stuffy nose have been reported.

Avoid using before driving motorized vehicles. Cannabis may increase the risk of collision, and when combined with alcohol, it may affect alertness and driving performance considerably.

Cannabis may also cause blood rush or dizziness when standing, a burning sensation, cannabis arteritis (reduced blood flow to feet and legs), changes in brain structure, changes in chromosomes, changes in erectile function, changes in quality of life, confusion, detachment from surroundings, difficulty concentrating, dysphoria (feeling unhappy or unwell), euphoria (feeling of happiness or well-being), forgetfulness, hoarseness, increased risk of male cancers, liver problems (damage, disorders, or poisoning), panic, paranoid thinking, problems with bowel movements, psychiatric problems, reduced saliva, reduced sperm production, risky behaviours (unprotected sex), sudden stomach upset, sweating, thirst, throat irritation, urinary tract infection, and weight gain.

Cannabis Oil has been seen to lower the blood pressure slightly. If you are on blood pressure medication e.g. ‘Ramipril’, or a derivative of ‘Hydroxybenzoate’ etc. then you may need to monitor and eventually come off the blood pressure medications. ALWAYS CONSULT YOUR GP. Please be aware of this when taking the oil if this affects you. If you have low blood pressure issues also it would be advisable to get a blood pressure monitoring system. Chemotherapy or radiotherapy increase blood pressure so it is ok to take the oil alongside these treatments but again always monitor your blood pressure yourself.

Pregnancy and Breastfeeding

Cannabis may affect the mother’s judgment and ability to care for the child. Individual research is advised.

Interactions with Drugs

Cannabis may increase the risk of bleeding when taken with drugs that increase the risk of bleeding. Some examples include aspirin, anticoagulants (blood thinners) such as warfarin (Coumadin®) or heparin, antiplatelet drugs such as Clopidogrel (Plavix®), and nonsteroidal anti-inflammatory drugs such as ibuprofen (Motrin®, Advil®) or naproxen (Naprosyn®, Aleve®).

Cannabis may affect blood sugar levels. Caution is advised when using medications that may also affect blood sugar. People taking drugs for diabetes by mouth or insulin should be monitored closely by a qualified healthcare professional, including a pharmacist. Medication adjustments may be necessary. Cannabis may cause low blood pressure. Caution is advised in people taking drugs that lower blood pressure. Cannabis may interfere with the way the body processes certain drugs using the liver’s cytochrome P450 enzyme system. As a result, the levels of these drugs may be increased in the blood and may cause increased effects or potentially serious adverse reactions. People using any medications should check the package insert and speak with a qualified healthcare professional, including a pharmacist, about possible interactions. Cannabis may increase the amount of drowsiness caused by some drugs. Examples include benzodiazepines such as lorazepam (Ativan®) or diazepam (Valium®), barbiturates such as phenobarbital, narcotics such as codeine, some antidepressants, and alcohol. Caution is advised while driving or operating machinery. Cannabis may also interact with agents that may affect blood vessel width, agents that may affect the immune system, agents that may be toxic to the liver, agents that may improve breathing or treat lung disorders, agents that may increase appetite, agents that may treat heart disorders, agents that may treat nausea or vomiting, agents that may treat nervous system disorders, agents that may treat psychiatric disorders, agents that may treat retrovirus infections (HIV), agents that may treat skin disorders, agents that may treat stomach disorders, anabolic steroids, anticancer agents, antipyrine, anti-seizure agents, bromo-dragonFLY, cannabinoid CB1 receptor antagonists, central nervous system depressants, cocaine, corticosteroids, dopamine antagonists, ecstasy, oestrogens, fertility agents, hormonal agents, nicotine, nonsteroidal anti-inflammatory agents, opioid receptor antagonists, pain relievers, p-glycoprotein-regulated agents, prochlorperazine, sedatives, and synthetic cannabinoids.

Interactions with Herbs and Dietary Supplements

Cannabis may increase the risk of bleeding when taken with herbs and supplements that are believed to increase the risk of bleeding. Multiple cases of bleeding have been reported with the use of Ginkgo Biloba, and fewer cases with garlic and saw palmetto. Numerous other agents may theoretically increase the risk of bleeding, although this has not been proven in most cases.

Cannabis may affect blood sugar levels. Caution is advised when using herbs or supplements that may also affect blood sugar. Blood sugar levels may require monitoring, and doses may need adjustment. Cannabis may cause low blood pressure. Caution is advised in people taking herbs or supplements that lower blood pressure. Cannabis may interfere with the way the body processes certain herbs or supplements using the liver’s cytochrome P450 enzyme system. As a result, the levels of other herbs or supplements may become too high in the blood. It may also alter the effects that other herbs or supplements possibly have on the P450 system. Cannabis may increase the amount of drowsiness caused by some herbs or supplements.

Cannabis may also interact with anabolic steroids, anti-cancer herbs and supplements, antioxidants, anti-seizure herbs and supplements, barbiturates, benzodiazepines, central nervous system depressants, corticosteroids, dopamine antagonists, fertility herbs and supplements, herbs and supplements that may affect blood vessel width, herbs and supplements that may affect the immune system, herbs and supplements that may be toxic to the liver, herbs and supplements that may improve breathing or treat lung disorders, herbs and supplements that may increase appetite, herbs and supplements that may treat heart disorders, herbs and supplements that may treat nausea and vomiting, herbs and supplements that may treat nervous system disorders, herbs and supplements that may treat psychiatric disorders, herbs and supplements that may treat retrovirus infections (HIV), herbs and supplements that may treat skin disorders, herbs and supplements that may treat stomach disorders, hormonal herbs and supplements, nicotine, nonsteroidal anti-inflammatories, opioid receptor antagonists, pain relievers, p-glycoprotein-regulated herbs and supplements, phytoestrogens, and synthetic cannabinoids.

This information is based on a systematic review of scientific literature. Some of these conditions are potentially serious, and should be evaluated by a qualified healthcare provider.

Chronic Pain Cannabis has been studied for the treatment of chronic pain. It has been used in people whose pain did not respond to other drugs. Cannabis-based products like Sativex® are used to treat different types of pain, such as pain from cancer or multiple sclerosis. It is approved in Canada and many parts of Europe. In the United States, it is being studied in people who have cancer-related pain. Other cannabis-based products, such as the U.S. Food and Drug Administration (FDA)-approved dronabinol (Marinol®), are also being studied.

Multiple Sclerosis Cannabis has been studied for the relief of multiple sclerosis symptoms, such as nerve pain, muscle spasms, and urinary disorders. The active ingredients have effects on the central nervous system and immune cells. Cannabis works extremely well at treating the symptoms of M.S.

Amyotrophic Lateral Sclerosis (nerve cell disease) Current studies show that THC may lack benefit in people who have amyotrophic lateral sclerosis. More research is needed.

Appetite Stimulant Current studies show that cannabis-based therapy may lack benefit on weight loss and anorexia related to cancer. Early studies suggested that cannabis may improve appetite in people who have cystic fibrosis (mucus build-up in the organs) and AIDS. More research is needed.

Atopic Dermatitis (itchy, scaly skin rashes) Hemp seed oil may help reduce symptoms of atopic dermatitis, a chronic skin disorder that causes itchy, scaly rashes. This benefit is believed to come from the fatty acids in hemp seed oil. Further research is needed.

Brain Injuries Cannabis has been studied for potential benefit in people with acute brain injury. However, more research is needed before conclusions can be made.

Chemotherapy Side Effects Studies suggest that cannabis may help reduce nausea and vomiting in people undergoing chemotherapy. However, it may cause side effects such as sleepiness and changes in mood. One review suggests that cannabis may cause more side effects in children undergoing chemotherapy than other therapies. However, the effect of cannabis alone is unclear, and further research is needed.

Dementia Early studies suggest that cannabis may benefit weight gain and behaviour in people who have dementia. More research is needed before conclusions can be made.

Eating disorders In patients with eating disorders THC had a lack of effect on weight, caloric intake, and psychiatric assessment. Further research is required.

Epilepsy New research on Cannabis and epilepsy has proven certain combinations of cannabis are in fact excellent at reducing seizures in epilepsy cases. Significantly, in children, where amazing results have been observed forcing legislation changes in the UK.

Glaucoma (high eye pressure) People who have glaucoma have high pressure in the eye, which may lead to optic nerve damage and vision loss. Some studies suggest that THC may lower eye pressure, while CBD may lack benefit or actually increase pressure. More research is needed to understand the possible role of cannabis in glaucoma treatment.

Huntington’s disease (nerve cell death in brain) Symptoms of Huntington’s disease include impaired brain function and jerky body movements. Early research suggests that CBD may lack effect on movement problems caused by Huntington’s, although the Cannabis-based drug Nabilone may have benefits. More studies are needed in this area.

Neuromuscular disorders Cannabis has been studied in the treatment of symptoms of nerve and muscle disorders. Researchers looked for possible benefits on appetite, saliva production, mood, muscle health, and sleep. More research is needed before conclusions can be made.

Rheumatoid Arthritis Research shows that cannabis reduces pain and improve sleep quality in people who have rheumatoid arthritis. The anti-inflammatory property’s of CBD combined with the Entourage Effect reduce pain and inflammation in the joints.

Schizophrenia: Early research suggests that CBD may lack effect in people who have schizophrenia. Other research reports that cannabis users may have better brain function than non-users. However, long-term use of cannabis has been linked to a higher risk of psychiatric problems. These include bipolar disorder, anxiety, suicidal thoughts, depression, delusions, hallucinations, aggression, and lack of motivation or energy. More research is needed.

Sleep disorders Limited research suggests that CBD may help people who have problems sleeping. However, more studies are needed before conclusions can be made.

Tourette’s syndrome (brain disorder causing tics) Some research reports that Cannabis may improve some symptoms of Tourette’s syndrome. However, significant benefit over placebo is lacking for tics and other symptoms. More research is needed in this area.

Clinical Studies on the action of cannabinoids against cancer:

• Anti-tumour effects of Cannabis. Updated publications on the website of the National Cancer Institute of the Government of the United States in May 2014.
• Preparation and characterisation of biodegradable micro particles filled with THC and their anti-tumour efficacy on cancer cell lines. Study published in the Journal of Drug Targeting in September 2013.
• The endocannabinoid system: a therapeutic target for regulating the growth of cancer.
• Study published in the Life Science journal in March 2013.
• CBD Cannabidiol as a potential anti-cancer drug. Study published in the British Journal of Pharmacology in February 2013.
• Cannabinoids as anti-cancer modulators. Study published in the Progress in Lipid Research journal in January 2013.
• CBD inhibits angiogenesis by multiple mechanisms. Study published in the British Journal of Pharmacology in November 2012.
• Towards the use of cannabinoids as anti-tumour agents. Study published in Nature in June 2012.
• Cannabinoid-associated cell death mechanisms in tumour models. Study published in the International Journal of Oncology in May 2012.
• Cannabinoids, endocannabinoids and cancer. Study published in Cancer Metastasis Reviews in December 2011.
• The endocannabinoid system and cancer: therapeutic implication. Study published in the British Journal of Pharmacology in July 2011.

Cannabis against brain cancer (glioma, glioblastoma…)

• Cannabidiol (CBD), a non-psychoactive cannabinoid compound, inhibits the proliferation and invasion in U87-MG and T98G glioma cells through a multi-target effect. Study published in the Public Library of Science journal in October 2013.
• CBD, a novel therapeutic target against glioblastoma. Study published in Cancer Research in March 2013.
• Local delivery of cannabinoid-filled micro particles inhibits tumour growth in a model of glioblastoma multiforme. Study published in Public Library of Science in January 2013.
• Cannabinoid action inhibits the growth of malignant human glioma U87MG cells. Study published in Oncology Reports in July 2012.
• A combined preclinical therapy of cannabinoids and temozolomide against glioma. Study published in Molecular Cancer Therapeutics in January 2011.
• Cannabidiol enhances the inhibitory effects of THC on human glioblastoma cell proliferation and survival. Study published in the Molecular Cancer Therapeutics journal in January 2010.
• Cannabinoid action induces autophagy-mediated cell death in human glioma cells. Study published in The Journal of Clinical Investigation in May 2009.
• Cannabinoids inhibit glioma cell invasion by down-regulating matrix metalloproteinase-2 expression. Study published in Cancer Research in March 2008.
• Cannabinoids and gliomas, a study published in Molecular Neurobiology in June 2007.
• Cannabinoids inhibit gliomagenesis. Study published in the Journal of Biological Chemistry in March 2007.
• A pilot clinical study of THC in patients with recurrent glioblastoma multiforme. The results were published in the British Journal of Cancer in June 2006.
• Cannabidiol inhibits human glioma cell migration through an independent cannabinoid receptor mechanism. Study published in the British Journal of Pharmacology in April 2005.
• Cannabinoids inhibit the vascular endothelial growth factor pathway (VEGF) in gliomas. Study published in the Journal of Cancer Research in August 2004.
• Anti-tumour effects of cannabidiol, a non-psychoactive cannabinoid, on human glioma cell lines. Study published in the Journal of Pharmacology in November 2003.
• Inhibition of glioma growth in vivo by selective activation of the CB₂ cannabinoid receptor. Study published in the Journal of Cancer Research in August 2001.

Cannabis and breast cancer

• Targeting multiple cannabinoid anti-tumour pathways with a resorcinol derivative leads to inhibition of advanced stages of breast cancer. Study published in the British Journal of Pharmacology in June 2014.
• CBDA, an acid form of CBD found in fibre-type cannabis, is an inhibitor of MDA-MB-231 breast cancer cell migration. Study published in Toxicology Letters in November 2012.
• Cannabinoids: A new hope for breast cancer therapy? Study published in Cancer Treatment Reviews in June 2012.
• Pathways mediating the effects of cannabidiol on the reduction of breast cancer cell proliferation, invasion, and metastasis.  Study published in Breast Cancer Research and Treatment in August 2011.
• CBD induces programmed cell death in breast cancer cells by coordinating the cross-talk between apoptosis and autophagy. Study published in Molecular Cancer Therapeutics in May 2011.
• Cannabinoids reduce ErbB2-driven breast cancer progression.  Study published in Molecular Cancer in July 2010.
• CBD as a novel inhibitor of Id-1 gene expression in aggressive breast cancer cells. Study published in Molecular Therapeutics Research in November 2007.
• Anti-tumour activity of plant cannabinoids with emphasis on the effect of cannabidiol on human breast carcinoma. Study published in the Journal of the American Society for Pharmacology and Experimental Therapeutics in May 2006.
• THC inhibits cell cycle progression in human breast cancer cells through Cdc2 regulation. Study published in Cancer Research in July 2006.

Cannabis against blood cancer (leukaemia, myeloma, lymphoma…)

• The effects of cannabidiol and its synergism with bortezomib in multiple myeloma cell lines. Study published in the International Journal of Cancer in December 2013.
• Enhancing the activity of CBD and other cannabinoids against leukaemia. Study published in Anticancer Research in October 2013.
• Cannabis extract treatment for terminal acute lymphoblastic leukaemia of Philadelphia chromosome (Ph1). Study published in Case Reports in Oncology in September 2013.
• Expression of type 1 and type 2 cannabinoid receptors in lymphoma. Study published in the International Journal of Cancer in June 2008.
• Cannabinoid action in mantle cell lymphoma. Study published in Molecular Pharmacology in November 2006.
• THC-induced apoptosis in Jurkat leukaemia. Study published in Molecular Cancer Research in August 2006.
• Targeting CB2 cannabinoid receptors as a novel therapy to treat malignant lymphoblastic disease. Study published in Blood American Society of Haematology in July 2002.

Cannabis against lung cancer

• Cannabinoids increase lung cancer cell lysis by lymphokine-activated killer cells via upregulation of Icam-1. Study published in Biochemical Pharmacology in July 2014.
• Cannabinoids inhibit angiogenic capacities of endothelial cells via release of tissue inhibitor of matrix metalloproteinases-1 from lung cancer cells. Study published in Biochemical Pharmacology in June 2014.
• COX-2 and PPAR-γ confer CBD-induced apoptosis of human lung cancer cells. Study published in Molecular Cancer Therapeutics in January 2013.
• CBD inhibits lung cancer cell invasion and metastasis via intercellular adhesion molecule-1. Study published in the Journal of the Federation of American Societies for Experimental Biology in April 2012.
• Cannabinoid receptors, CB1 and CB2, as novel targets for inhibition of non–small cell lung cancer growth and metastasis. Study published in Cancer Prevention Research in January 2011.
• THC inhibits epithelial growth factor-induced (EGF) lung cancer cell migration in vitro as well as its growth and metastasis in vivo. Study published in the journal Oncogene in July 2007.

Cannabinoids against colorectal cancer

• Inhibition of colon carcinogenesis by a standardised Cannabis Sativa extract with high content of CBD. Study published in Phytomedecine in December 2013.
• Chemo preventive effect of the non-psychotropic phytocannabinoid CBD on colon cancer. Study published in the Journal of Molecular Medicine in August 2012.
• Cannabinoids against intestinal inflammation and cancer. Study published in Pharmacology Research in August 2009.
• Action of cannabinoid receptors on colorectal tumour growth. Study published by the Cancer Centre of the University of Texas in July 2008.

Cannabis and stomach cancer

• Cannabinoid receptor agonist as an alternative drug in 5-Fluorouracil-resistant gastric cancer cells. Study published in Anticancer Research in June 2013.
• Anti-proliferative mechanism of a cannabinoid agonist by cell cycle arrest in human gastric cancer cells. Study published in the Journal of Cellular Biochemistry in March 2011.

Cannabis against prostate cancer

• Non-THC cannabinoids inhibit prostate carcinoma growth in vitro and in vivo: pro-apoptotic effects and underlying mechanisms. Study published in the British Journal of Pharmacology in December 2012.
• The role of cannabinoids in prostate cancer: Basic science perspective and potential clinical applications. Study published in the Indian Journal of Urology in January 2012.
• Induction of apoptosis by cannabinoids in prostate and colon cancer cells is phosphatase dependent. Study published in Anticancer Research in November 2011.

Cannabis against liver cancer

• Involvement of PPAR-γ in the anti-tumour action of cannabinoids on hepatocellular carcinoma (CHC). Study published in Cell Death and Disease in May 2013.
• Evaluation of anti-invasion effect of cannabinoids on human hepatocarcinoma cells. Study published on the site Informa Healthcare in February 2013.
• Anti-tumoural action of cannabinoids on hepatocellular carcinoma. Study published in Cell Death and Differentiation in April 2011.

Cannabis against pancreatic cancer

• Cannabinoids inhibit energetic metabolism and induce autophagy in pancreatic cancer cells. Study published in Cell Death and Disease in June 2013.
• Cannabinoids Induce apoptosis of pancreatic tumour cells. Study published in Cancer Research in July 2006.

Cannabis against skin cancer

• Cannabinoid receptors as novel targets for the treatment of melanoma. Study published in the Journal of the Federation of American Societies for Experimental Biology in December 2006.
• Inhibition of skin tumour growth and angiogenesis in vivo by activation of cannabinoid receptors. Study published in the Journal of Clinical Investigation, in January 2003.

Cannabis against other types of cancer

• Bladder: Cannabis reduces the risk of bladder cancer. Study published in the Medscape site in May 2013.
• Kaposi sarcoma: Cannabidiol inhibits growth and induces programmed cell death in Kaposi sarcoma–associated herpesvirus-infected endothelium. Study published in the journal Genes & Cancer in July 2012.
• Nose, mouth, throat and ear: Cannabinoids like THC inhibit cellular respiration of human oral cancer cells. Study by the Department of Paediatrics at the State University of New York, published in June 2010.
• Bile duct: The dual effects of THC on cholangiocarcinoma cells: anti-invasion activity at low concentration and apoptosis induction at high concentration. Study published in Cancer Investigation in May 2010.
• Ovaries: Cannabinoid receptors as a target for therapy of ovarian cancer. Study published on the American Association for Cancer Research website in 2006.

Finally, it is worth highlighting from these publications that the efficacy of cannabinoids against cancer depends on the dose: the higher the dose, the more important the action.

Since it is difficult to obtain high and constant blood concentrations of cannabinoids by consuming cannabis plants in the usual ways (smoking, vaporizing…) most patients use extractions of cannabinoids. We greatly appreciate the research work carried out by Dr Manuel Guzman’s team at the Universidad Complutense de Madrid for their current work on the use of cannabinoids against cancer. Do not hesitate to share this information in your community, particularly if you know doctors already involved with cancer research, and obviously with friends and family suffering from this disease or any other illness who are seeking a natural, safe and extremely effective complementary therapy.

THC and other Cannabinoids
The oil contains cannabinoids, and it is these that do the magic! Over 100 different Cannabinoids have been isolated so far, THC being the most well-known and which is responsible for killing cancers and shrinking tumours. Others include CBD which prevents cancer growing and is also a fantastic anti-inflammatory.
There are many cannabinoids in each strain of plant, with different ratios and different levels. The cannabinoid profile of each oil strain is different.
Some of the main cannabinoids and some of their effects:

THC    (psychoactive component) kills cancer/ simulates appetite.

CBD    stops cancer growing/reduces vomiting/nausea/ lowers seizures.

THCv  Reduces appetite/ lowers seizures/promotes bone growth.

CBC    Pain relief/stops cancer cell growth/reduces inflammation.

CBG   kills or slows bacteria growth/stops tumour growth/ anti inflammatory.

CBN   Aids sleep/reduces spasms/ causes drowsiness.

Even the ‘Terpenes’ and ‘Flavonoids which are the actual scent/smell and tastes of the various female cannabis plant strains also have medicinal value by themselves.

There are other forms of cannabis oil available on the market – most commonly used are three types known in the industry as RSO, BHO and CO2.

RSO – Rick Simpson Oil

Rick Simpson rediscovered for the masses that cannabis oil cures cancer and it is thanks to Rick Simpson for the advancements in proliferation of knowledge of cannabis and its recreation and legislation worldwide – but the RSO Method requires 100% Ethanol or as Rick says “Light Aliphatic Naptha” (aka Petroleum Ether – 100% Ethanol or ‘100% Pure Grain Alcohol is illegal in most countries without a distillers licence and therefore it is very hard to obtain medicinal grade Petroleum ether for drug manufacture without a university research licence or similar, which has led to a popular myth that a similar substance: ‘99% Isopropyl Alcohol’ which is widely available on  popular internet shopping sites on offer as a circuit board cleaning product. 99% Isopropyl Alcohol is not a clean alcohol, it is contaminated with toxic and carcinogenic chemicals like Benzene and toluene and other heavier hydrocarbons knows as ligroins, octane and decane. Not only is it toxic, but it has too high a boiling point to effectively remove without the use of a vacuum pump – Having said that, It is better than nothing and its cured thousands of people. But there is a better cleaner way, and that is our mission.

BHO – Butane Honey Oil – Butane Hash Oil

Butane Honey Oil extraction or BHO refers to the method used to extract the essential oils from the cannabis plant via n-Butane and sometimes a mix of n-Butane and n-Propane. Perhaps the first question is why use a BHO technique to extract the resins, instead of just boiling the material in alcohol to get the greatest amount of extracted material?

The answer to that is that because butane is relatively non-polar, it doesn’t extract the water-soluble chlorophyll and plant alkaloids. Butane produces one of the cleanest extractions, albeit typically at a lower yield than by polar alcohol. Vacuum Oven purged BHO contains only the desired material, the butane is highly volatile and the heat and vacuum purge 100% of the butane from the concentrate if done correctly by a qualified E.A. (Extract Artist) The only remaining contaminants (if present as it is possible to remove them first before extraction) are collectively known as ‘mystery-oils’.

Mystery oils are the residue oils left over from the butane can manufacturing process in much the same ways as all tinned & canned products are created. The subject of mystery oils is controversial. One argument is that sitting in a traffic jam on a motorway for 20 minutes will cause more harm than the almost ‘homeopathic’ level of mystery oils contained in a preparation of vacuum purged and decarboxylated THC concentrate. The decarboxylation process requires heat of up to 120 degrees Celsius which will most likely ‘cook off’ most, if not all, remaining mystery oils.

Another argument is that due to the nature of the name ‘mystery-oils’ they are by definition still a mystery and not enough is known. Either way BHO extracts are far better, cleaner and purer than RSO and other alcohol extraction techniques. With BHO the hydrocarbons in the n-butane are only heavy enough to drag with them the plant ‘Trichomes’ (the tiny mushroom protrusions, clear crystal like resembling sugar in appearance on the outside of female cannabis flowers)

It is in the plants Trichomes where we find all the medicinal components, in particular THC and all the other spectrum cannabinoids, and it is these that we are interested in removing for blending and transformation into the multi-strain True-Full Spectrum cannabinoid oil.

Extracts made by the RSO Technique are easy to spot as it is usually a black ‘tarry’-looking substance commonly sold in pre-made plastic syringes. RSO is a mixture of plant material boiled in Isopropyl Alcohol and strained. Its black colour comes from the high amount of unnecessary plant material boiled in the mixture – chlorophyll which makes the leaves green in colour, plant lipids and fats along with any un-flushed plant nutrient salt build-ups and deposits from mineral nutrients during the grow and bloom phase of the crop which have not been correctly flushed out at the end of the cycle. Most plant grow feeds are mineral-based but a lot has been manufactured in the Far East using lower quality precursor products and techniques in the synthesis of the nutrient make-up. There are also some products on the market that contain PGR’s (Plant Growth Regulators) and is the plant is not flushed correctly can cause health issues if inhaled or ingested. Often lazy growers who make black-market RSO have their crops invaded by ‘Spider-Mite’ (Tetranychidae) during summer indoor growing. These un-schooled growers often use banned pest control items to stop such debilitating infestations that these little critters can cause, but these banned substances are extracted out into the cannabis oil during manufacture. So it is important to use only the highest quality organic flower possible to make cannabis extracts into a consumable medication.

Gold nourishing cannabinoids suspended and mixed only with pure Organic Hemp Seed Oil as a carrier solution. When we de-wax and de-winterise our extracts we remove the natural lipids and fats contained within the Trichomes of the female cannabis plant. Once the natural lipids and fats have been removed, this then leaves the decarboxylated extract able to bond more easily with any natural fat (olive oil, coconut oil, butter etc)

Hemp seed oil is perfect, it also exhibits the highest total phenolic content and antioxidant activity compared to all other plant-based oils (with the exception of pumpkin seed oil). Naturally occurring phenolic compounds are known to play a key role in reducing the risk of cancer, relieving systemic inflammation, acting as a powerful antioxidant and promoting free radical elimination. In addition to being safe to consume, hemp seed oil is more sustainable than fish oil because it does not upset ocean ecosystems and reduce sizable fish populations necessary to support fish living in the upper areas of the food chain. In addition, hemp plants are pest and disease resistant, help reduce greenhouse gases in the atmosphere, and high in Omega 3.

Our crops are fed with natural spring water filtered through hundreds of meters of rock before flowing out naturally through a formation of stone on our terraced grow location – situated high up a mountain in one of Spain’s most beautiful regions with the perfect weather and altitude for growing the strains that we use in research for our medications. Benefiting from some of the finest natural water available on the planet, snow and glacier melt water filtered through solid rock over hundreds of years to come out naturally on the land our grow location occupies, giving Medi-Cure Bio-Ergonomics ™The perfect water with a TDS reading of Zero from source – TDS is Total Dissolved Solid of a solution. In simple terms, water is a poor conductor, so when an electrical current of a TDS meter is introduced, it will show up a reading based on the strength of electrical current between two probes on the meter – the higher the reading the higher the content of other chemicals like chlorine, fluoride, plant nutrients will be present. Plant nutrient strength is measured in this way.

Grown in ideal conditions, lovingly prepared to make a profoundly wholesome organic and natural booster for the immune system with so many health benefits – created out of the very same building blocks that are also by coincidence or design our body’s own natural first line of defence i.e. cannabinoids and the endocannabinoid system CB1 and CB2 receptors in the brain and body.

Key to this process is the accumulation of ceramide in the system. This means taking therapeutic amounts of CBD and THC and other spectrum cannabinoids, steadily over a period of time. This is known as ‘Micro Dosing’ – keeping metabolic pressure on this cancer cell death pathway.

Why is it that the body can take a simple plant enzyme and use it for profound healing in many different physiological systems?

The endocannabinoid system exists in all animal life, just waiting for its matched cannabinoid activator. Our own endocannabinoid system covers all cells and nerves. It is the messenger of information flowing between our immune system and the central nervous system (CNS). It is responsible for neuroprotection, and micro-manages the immune system. This is the primary control system that maintains homeostasis, our wellbeing. Don’t forget to look at changing your diet by reading the Medi-Cure Bio-Ergonomics ™ ‘Diet guide’ found here on this website in our Diet page containing vital information to help you keep a disease and illness-free Alkalized body in perpetual homeostasis.

There are at least 113 different cannabinoids isolated from the cannabis plant so far, exhibiting varied effects. Listed below are some of the main cannabinoids commonly seen:

THC Tetrahydrocannabinol – THCA Tetrahydrocannabinolic acid – CBD Cannabidiol – CBDA Cannabidiolic Acid – CBN Cannabinol – CBG Cannabigerol – CBC Cannabichromene – CBL Cannabicyclol – CBV Cannabivarin – THCV Tetrahydrocannabivarin – CBDV Cannabidivarin – CBCV Cannabichromevarin – CBGV Cannabigerovarin – CBGM Cannabigerol Monomethyl Ether – CBE Cannabielsoin – CBT Cannabicitran.

Remember – Cannabis has got at least a 7,000 year safety record – no one has ever died from taking Cannabis. How does that compare with Chemotherapy we wonder?

Any further questions or to join our mailing list with information on new products and industry news – then please contact us at: www.medi-cure.uk

Finally………Almost everything on the NHS website link below about cannabis is a complete Lie. These are not ‘mistakes’ by the author/s….they are perpetrated lies from the very top down, because the only thing that this plant can damage is Big Pharma’s Profits. Dont be fooled. Do your own research.

https://www.nhs.uk/conditions/medical-cannabis/

G-5C1YK2DLWF